Member News Steven Scott Member News Steven Scott

Roslin Tech announce Dr Deepika Rajesh as Chief Science Officer

Roslin Technologies, a life science company in Edinburgh focused on cultivated meat, has announced the appointment of Dr Deepika Rajesh to the role of Chief Scientific Officer. Deepika brings a wealth of stem cell experience to the company. Her appointment reflects Roslin Technologies’ commitment to advancing its animal stem cell platform for the emerging cultivated meat sector and ensures that robust science is at the heart of the company.  

Read More
Member News Steven Scott Member News Steven Scott

Innovative MiAlgae champions growth of next generation biotech talent

Scottish biotechnology innovator, MiAlgae, a producer of sustainable Omega-3 rich ingredients from algae, has announced new additions to its growing team. Supporting skills development and training opportunities, the company recently welcomed two eager Foundation Apprentices on board, in addition to three PhD students who are currently completing placements. 

Read More
Member News Steven Scott Member News Steven Scott

Government Minister visits Celtic Renewables on launch of new Circular Economy Bill

Celtic Renewables are at the forefront of maximising the generation of value from biological residues, and on launching the new circular economy bill Minister Slater visited the company’s plant at Grangemouth to see first-hand how by-products of the whisky industry are processed into high-value low-carbon green chemicals that are used in our daily lives.

Read More
Steven Scott Steven Scott

Roslin Tech announces new investment from Kickstart Ventures

Edinburgh-based food tech company, Roslin Technologies, is delighted to welcome Philippine-based Kickstart Ventures, through the Ayala Corporation Technology Innovation Venture (ACTIVE) Fund, as an investor in the Company to support its mission to become the leading provider of animal cell lines to the global cultivated meat industry. 

Read More
Member News, Industry News Steven Scott Member News, Industry News Steven Scott

Lentitek secures £250k seed investment to commercialize enabling biotechnologies for advanced cancer treatments and gene therapies

Edinburgh based Lentitek Ltd (Lentitek), a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, announced today that it has secured £250,000 ($300,000 USD) in seed investment.  This investment will be deployed to further advance its technology and commence initial commercial trials. 

Read More